Immucell (ICCC) Non-Current Debt (2010 - 2026)

Immucell (ICCC) has reported Non-Current Debt for 17 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt changed 0.48% year-over-year to $8.3 million; the trailing twelve-month figure through Jun 2026 stood at $8.3 million (changed 0.48% YoY), and the FY2025 full-year result was $7.5 million, down 17.17% from the prior year.
• Non-Current Debt grew to $8.3 million in Q2 2026 per ICCC's latest filing, from $7.5 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $12.3 million in Q3 2023 and bottomed at $7.5 million in Q4 2025.
• Historically, Non-Current Debt has averaged $9.5 million across 5 years, with a median of $9.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt gained 29.93% in 2023, then dropped 23.49% in 2024.
• Over 5 years, Non-Current Debt stood at $9.2 million in 2022, then gained by 14.68% to $10.5 million in 2023, then decreased by 14.23% to $9.0 million in 2024, then retreated by 17.17% to $7.5 million in 2025, then gained by 10.87% to $8.3 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $8.3 million, $7.5 million, and $9.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.